Weekly Must Knows For Week Of 6/15/2020

Welcome to another trading week!! In appreciation of all of our Basic Membership level participants and daily readers of finomgroup.com content, we offer the following excerpts from our Weekly Research Report. Our weekly report is extremely detailed and has proven to help guide investors and traders during all types of market conditions with thoughtful insights and analysis, graphs,…

Protests Can’t Pin Markets Down: Why?

As daily protests/marches/demonstrations continue, the equity markets also continue to trend higher. On Tuesday, the S&P 500 (SPX) added to it’s record setting bounce off of the March 23r lows by tacking on another 25 points. A quick look at the 1-day chart of the benchmark index below identifies a massive surge in volume and…

Weighing the Good and Bad In Markets

Over the last couple of weeks, we’ve been able to compile and discern all the characteristics of a bear market that was on a path to reinstalling a bull market. The key variables identifying such a probable outcome for the market were based on market leadership, structure, breadth and moving averages. As of the close…

Weekly Must Knows For Trading Week 6/1/2020

Welcome to another trading week!! In appreciation of all of our Basic membership level participants and daily readers of finomgroup.com content, we offer the following excerpts from our Weekly Research Report. Our weekly report is extremely detailed and has proven to help guide investors and traders during all types of market conditions with thoughtful insights and analysis, graphs,…

The Weekly 8 Must Knows In the Markets

Welcome to another trading week!! In appreciation to all of our Basic membership level participants and daily readers of finomgroup.com content, we offer the following excerpts from our Weekly Research Report. Our weekly report is extremely detailed and has proven to help guide investors and traders during all types of market conditions with thoughtful insights and analysis,…

That Funky Cold Moderna Drives Markets Higher

Global equity markets soared on Monday as headlines surrounding Moderna’s phase-1 trial results for a COVID-19 vaccine proved promising. J.P. Morgan’s Biotech analysts offered there reaction and analysis to clients in a note on Monday as follows: Quick Takes from the Conference Call: The neutralizing titers seen from the Phase 1 results were consistent with…